HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 X64_SR12 19JUL21:19:59:0319JUL21:19:59:03 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS ADARP7D SASDATA 9.4 X64_SR12 19JUL21:19:59:0319JUL21:19:59:03 Solicited AR post D7 Analysis Dataset HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000008600000000000000000000 STUDYID Study Identifier USUBJID Unique Subject Identifier  SUBJID Subject Identifier for the Study 'SITEID Study Site Identifier 0COUNTRY Country 5AGE Age 8AGEU Age Units @AGEGR1 Pooled Age Group 1 E AGEGR1N Pooled Age Group 1 (N) W AGEGR2 Pooled Age Group 2 _ AGEGR2N Pooled Age Group 2 (N) r SEX Sex z) RACE Race {'RACESPY Race Specify ETHNIC Ethnicity RANDFL Randomized Population Flag SAFFL Safety Population Flag FASBABFLFull Analysis Set bAb Population Flag FASNABFLFull Analysis Set nAb Population Flag PPBABFL Per Protocol bAb Population Flag PPNABFL Per Protocol nAb Population Flag PPBD29FLPer Protocol bAb Day 29 Flag PPBD57FLPer Protocol bAb Day 57 Flag PBD209FLPer Protocol bAb Day 209 Flag PPND29FLPer Protocol nAb Day 29 Flag PPND57FLPer Protocol nAb Day 57 Flag PND209FLPer Protocol nAb Day 209 Flag SAR1FL First Solicited Safety Population Flag SAR2FL Second Solicited Safety Population Flag SARAFL Solicited Safety Population Flag FASNA2FLFAS nAb 2 Population Flag  PPNAB2FLPP nAb 2 Population Flag !PN2D29FLPer Protocol nAb 2 Day 29 Flag "PN2D57FLPer Protocol nAb 2 Day 57 Flag #PN2209FLPer Protocol nAb 2 Day 209 Flag $DVBABFL Deviation Impact bAb Flag %DVNABFL Deviation Impact nAb Flag &DOSE1FL Vaccination 1 Flag 'DOSE2FL Vaccination 2 Flag (DOSEROFLDosing Error Flag  )COV19BL Baseline COVID Infection *ELECSBL Baseline Elecsys SARS CoV-2 Assay +COV19FL COVID Infection Flag ,SENTLFL Sentinel Participant Flag -D29W7DFLDay 29 Out of 7-Day Window Flag  .TRT01P Planned Treatment for Period 01  /TRT01PN Planned Treatment for Period 01 (N) 0TRT01A Actual Treatment for Period 01 "1TRT01AN Actual Treatment for Period 01 (N) 22TR01SDT Date of First Exposure in Period 01 DATE :3TR01SDTMDatetime of First Exposure in Period 01 DATETIME B4TR01EDT Date of Last Exposure in Period 01 DATE J5TR01EDTMDatetime of Last Exposure in Period 01 DATETIME R6TRTSDTM Datetime of First Exposure to Treatment DATETIME Z7TRTEDTM Datetime of Last Exposure to Treatment DATETIME b8DOSE2DT Date of Dose 2 DATE j9DOS2DTM Datetime of Dose 2 DATETIME r:ASEQ Analysis Sequence Number z;ADT Analysis Date DATE ADY Analysis Relative Day  ?ATPTREF Analysis Timepoint Reference 1@ATPT Analysis Timepoint AATPTN Analysis Timepoint (N) BATPTGR1 Poolded Analysis Timepoint CATPTGR1NPoolded Analysis Timepoint (N) (DPARCAT1 Parameter Category 1 EPARCAT1NParameter Category 1 (N) FPARAMCD Parameter Code &_GPARAM Parameter .HAVAL Analysis Value ^IAVALC Analysis Value (C) JATOXGR Analysis Toxicity Grade KATOXGRN Analysis Toxicity Grade (N) LSRCDOM Source Data MSRCSEQ Source Sequence Number  NSRCVAR Source Variable  OFAEVAL Evaluator .PMAAEFL Medically Attended Flag ;QANL01FL Analysis Flag 01 <RANL02FL Analysis Flag 02 =SANL03FL Analysis Flag 03 >TANL04FL Analysis Flag 04 ?UANL05FL Analysis Flag 05 @VANL06FL Analysis Flag 06 A HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqADV3EHqUAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqA DV4EHq@A Vaccination 1DAY 2 A DAY 2 A LOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqA0DV5EHqA0Vaccination 1DAY 3 A0DAY 3 A0LOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqA@DV6EHqJ@A@Vaccination 1DAY 4 A@DAY 4 A@LOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqAPDV7EHqAPVaccination 1DAY 5 APDAY 5 APLOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqA`DV8EHq@A`Vaccination 1DAY 6 A`DAY 6 A`LOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqApDV9EHq>ApVaccination 1DAY 7 ApDAY 7 ApLOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqADV:EHq@AVaccination 1DAY 8 ADAY 8 ALOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqADV;EHqAVaccination 1DAY 9 ADAY 9 ALOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1007US2011007US201USABEYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNPlacebo APlacebo ADV3Hq dDVOHqHq dHqDVOHqADV<..AVaccination 1DAY 10 ADAY 10ALOCAL AERYTHDIAErythema Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1060US2011060US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq@ DVPHqb$Hq@ Hqb$DVPHqb$ADV8EiHqAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEk`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1060US2011060US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq@ DVPHqb$Hq@ Hqb$DVPHqb$A DV9E@Hq^dA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1060US2011060US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq@ DVPHqb$Hq@ Hqb$DVPHqb$A0DV;DHqDAVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1060US2011060US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq@ DVPHqb$Hq@ Hqb$DVPHqb$A@DV;EHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1060US2011060US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq@ DVPHqb$Hq@ Hqb$DVPHqb$APDV<EHq+AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1060US2011060US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq@ DVPHqb$Hq@ Hqb$DVPHqb$A`DV=E>HqhAVaccination 1DAY 10 ADAY 10ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,A@DVQDHq̎`BVaccination 2DAY 2 A DAY 2 A LOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEt@FASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,APDVRDHqBVaccination 2DAY 3 A0DAY 3 A0LOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEtPFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ApDVSDHq1`B Vaccination 2DAY 4 A@DAY 4 A@LOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEtpFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVTDHqЂB!Vaccination 2DAY 5 APDAY 5 APLOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVUDHq`B"Vaccination 2DAY 6 A`DAY 6 A`LOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVVDHq%B#Vaccination 2DAY 7 ApDAY 7 ApLOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVWDHqw`B$Vaccination 2DAY 8 ADAY 8 ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVXDHqB%Vaccination 2DAY 9 ADAY 9 ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVYDHq`B&Vaccination 2DAY 10 ADAY 10ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVZE7HqpB'Vaccination 2DAY 11 ADAY 11ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVPDpHqpBVaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,A DVQDHqBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEt FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,A0DVQDHquLBVaccination 2DAY 2 A DAY 2 A LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEt0FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,A`DVREHqkBVaccination 2DAY 3 A0DAY 3 A0LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEt`FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVTB<HqϾ<B!Vaccination 2DAY 4 A@DAY 4 A@LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVTE HqB!Vaccination 2DAY 5 APDAY 5 APLOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVUDHqѹ0B"Vaccination 2DAY 6 A`DAY 6 A`LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,ADVVE@HqӲDB#Vaccination 2DAY 7 ApDAY 7 ApLOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVWEHqB$Vaccination 2DAY 8 ADAY 8 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVXEHqRB%Vaccination 2DAY 9 ADAY 9 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVZC!HqשB'Vaccination 2DAY 10 ADAY 10ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDV[HqB(Vaccination 2DAY 11 ADAY 11ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVP..BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVQ..BVaccination 2DAY 2 A DAY 2 A LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVR..BVaccination 2DAY 3 A0DAY 3 A0LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVS..B Vaccination 2DAY 4 A@DAY 4 A@LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEu FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVT..B!Vaccination 2DAY 5 APDAY 5 APLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEu0FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVU..B"Vaccination 2DAY 6 A`DAY 6 A`LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEu@FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVV..B#Vaccination 2DAY 7 ApDAY 7 ApLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuPFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVW..B$Vaccination 2DAY 8 ADAY 8 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,BDVX..B%Vaccination 2DAY 9 ADAY 9 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,B DVY..B&Vaccination 2DAY 10 ADAY 10ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,B!DVZ..B'Vaccination 2DAY 11 ADAY 11ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,B"DV[..B(Vaccination 2DAY 12 ADAY 12ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,B#DV\..B)Vaccination 2DAY 13 ADAY 13ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,B$DV]..B*Vaccination 2DAY 14 ADAY 14ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,B%DV^..B+Vaccination 2DAY 15 ADAY 15ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1068US2011068US201USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4HqhDVPHq,HqhHq,DVPHq,B&DV_..B,Vaccination 2DAY 16 BDAY 16BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq DVPHqHq HqDVPHqADVQE@HqdBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq DVPHqHq HqDVPHqA DVTDHqfB!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq DVPHqHq HqDVPHqA0DVUEHqO0B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq DVPHqHq HqDVPHqA@DVVElHqӗB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq DVPHqHq HqDVPHqAPDVXBHqB%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq DVPHqHq HqDVPHqA`DVYD;Hq֐B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1084US2011084US201USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE HISPANIC OR LATINO YYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq DVPHqHq HqDVPHqApDVZD7HqB'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADVMEHqǢA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEm FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq A DVOCHq6pA@Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEm0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq A0DVOED@HqJA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEm@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq A@DVPEfHq˞`APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq APDVREHqFLApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq A`DVSEHHqϑAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ApDVTEHqAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADVUEHq.AVaccination 1DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADVVExHqӈAVaccination 1DAY 11 ADAY 11ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADVWE<HqLAVaccination 1DAY 12 ADAY 12ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADVXE`@HqJAVaccination 1DAY 13 ADAY 13ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADVYEHq׀AVaccination 1DAY 14 ADAY 14ASYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADVZE<HqAVaccination 1DAY 15 ADAY 15ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADV[E<HqLBVaccination 1DAY 16 BDAY 16BSYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq ADV\E<HqmBVaccination 1DAY 17 BDAY 17BSYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDV]E@HqܿBVaccination 1DAY 18 BDAY 18BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDV^E@HqBVaccination 1DAY 19 BDAY 19BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDV`D_dHqdBVaccination 1DAY 20 BDAY 20BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDV`E@HqBVaccination 1DAY 21 BDAY 21BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVaEHq @BVaccination 1DAY 22 BDAY 22BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVbEOHqWBVaccination 1DAY 23 BDAY 23BSYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVcE<HqLBVaccination 1DAY 24 BDAY 24BSYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVdE<HqBVaccination 1DAY 25 BDAY 25BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVMEHqǢA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVOCHq6pA@Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVOED@HqJA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVPEfHq˞`APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVREHqFLApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVSED@HqϐAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVTE@HqAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq BDVUEHq.AVaccination 1DAY 10 ADAY 10ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq B DVVExHqӈAVaccination 1DAY 11 ADAY 11ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq B"DVn..B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq B#DVo..B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US201-1123US2011123US201USAB@YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHq DVhHq Hq Hq DVhHq B!DViE@Hq쑈BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqA0DV8..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqAPDV9..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqA`DV:..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV;..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV<..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV=..AVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV>..AVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV?..AVaccination 1DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV@..AVaccination 1DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDVA..AVaccination 1DAY 15 ADAY 15ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDVB..BVaccination 1DAY 16 BDAY 16BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV3DHq*dAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqA DV7DXHqGAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqA@DV8E3Hq8A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqApDV:D͌HqDAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV;DxHq|AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV<DPHqPAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV=D(HqAVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqADV>DHqfAVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV?EHq78AVaccination 1DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDVADm8HqAVaccination 1DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDVADxHqeAVaccination 1DAY 15 ADAY 15ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDVBDHqBVaccination 1DAY 16 BDAY 16BSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV8..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV9..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV:..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV;..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV8E3Hq8A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1020US2021020US202USABHYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NYNmRNA-1273 50 ug A mRNA-1273 50 ug A DV3HqDVPHqHqHqDVPHqBDV:D͌HqDAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADVWEHqԽB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68A0DVXEHq0B"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68APDVYEHq`B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEmFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ApDVZEHqز0B$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEnFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADV[EHqB%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEn0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADV\EHqU0B&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEnPFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADV]EHqܦB'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEn`FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADV^EHq'B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68A DVWEHqlB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68A@DVXEHqAB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEmFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68A`DVZDHq&B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADV[DwHqpDB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADV^DtHqtB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADVWEHqlB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEp@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVXEHq4B"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEp`FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVYEHq׆lB#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVZEHqB$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV[EHq)lB%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV\EHqzB&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV]EHqlB'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV^EHqB(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEA0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV_DHq@B)Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEAPFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68ADVWD0HqEB!Vaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVWEHqlB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEpPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVXEHqAB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEppFASTRESC STUDY SUBJECTY Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVZDHq&B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV[DwHqpDB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV^DtHqtB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDV^EHq'B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVWD0HqEB!Vaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68BDVWEHqlB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B DVXEHqAB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B!DVZDHq&B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B"DV[DwHqpDB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B#DV^DtHqtB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEr FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B$DV^EHq'B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B%DVWEHqԽB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B'DVXEHq0B"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B)DVYEHq`B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FACEEsFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B+DVZEHqز0B$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FACEEs0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B-DV[EHqB%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FACEEsPFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B.DV\EHqU0B&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FACEEspFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B/DV]EHqܦB'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FACEEsFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B1DV^EHq'B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 3/SEVERE Grade 3A0FAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B&DVWEHqlB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A MYALGIA Myalgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B(DVXEHqAB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEsFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B*DVZDHq&B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEs FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B,DV[DwHqpDB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEs@FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1058US2021058US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV7Hq PDVWHq68Hq PHq68DVWHq68B0DV^DtHqtB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV7E@HqAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ A0DV8E@HqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ APDV9E@HqUA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ApDV:E@HqA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV;E@HqAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV<E@HqIA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEppFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV=E@HqApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV>E@HqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV?E@Hq>AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV@E@HqAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDVAE@HqAVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDVBE@Hq2AVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDVCE@HqAVaccination 1DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDVDDxHqAVaccination 1DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ A DV7E@HqAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ A@DV8EHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ A`DV:C]Hq|A@Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV:E HqǐA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV<C?HqA`Vaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV<E>Hq]A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ ADV=E0HqApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV>EHq AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV@DxHqAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV@E@HqyAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDVAEԀHqAVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDVCDkXHqAVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV8EHqHA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BBSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV:CV@Hq|dA@Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BCSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV:E@HqTA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BDSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV<C<HqA`Vaccination 1DAY 5 APDAY 5 APSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BESUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ BDV<E:Hq]A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B DV=E,HqLApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B!DV>EHq AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B"DV@DxHqAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BISUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B#DV8EHqHA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BBSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B$DV:CV@Hq|dA@Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BCSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B%DV:E@HqTA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BDSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B&DV<C<HqA`Vaccination 1DAY 5 APDAY 5 APSYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BESUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B'DV<E:Hq]A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B(DV=E,HqLApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B)DV>EHq AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1080US2021080US202USAB1YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqVDVXHqՉ HqVHqՉ DVXHqՉ B*DV@DxHqAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BISUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5Hq DVRHq<Hq Hq<DVRHq<A DVX..B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5Hq DVRHq<Hq Hq<DVRHq<A@DVY..B%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEA FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5Hq DVRHq<Hq Hq<DVRHq<A`DVZ..B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEA@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5Hq DVRHq<Hq Hq<DVRHq<ADVTE@HqB Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5Hq DVRHq<Hq Hq<DVRHq<A0DVXEYHq9B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1096US2021096US202USABYEARS>=18 and <55 YearsA>=23 and <=25 YearsA FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5Hq DVRHq<Hq Hq<DVRHq<APDVYEVHq׊B%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxA DV8EHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEm@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxA0DV9EHqAA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxAPDV:EHqA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxApDV;EHqAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV<EHq6A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV=EHqApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV>EHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV?EHq*AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV@De@Hq@AVaccination 1DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV8EHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEm0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxA@DV9EHqRA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEm`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxA`DV;DmHq60APVaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV<De|Hq|A`Vaccination 1DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV>Db4Hq4AVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxADV>DHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV8EHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV9EHqAA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV:EHqA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV;EHqAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV<EHq6A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV=EHqApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV>EHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV?EHq*AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV@DmHqͰAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV8EHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV=DT`HqApVaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV>Db4Hq4AVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV>DHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV;..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxB DV<..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEr0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxB!DV=..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxB#DV>..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxB%DV?..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxB&DV@..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV;DmHq60APVaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEr FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxBDV<De|Hq|A`Vaccination 1DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEr@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxB"DV>Db4Hq4AVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1144US2021144US202USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNPlacebo APlacebo ADV7Hq"XDVVHqxHq"XHqxDVVHqxB$DV>DHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADVXEfHq*`B"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘA@DVYEfHq{B#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘAPDVZEfHq`B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEqFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘApDV[EfHqB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEq FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV\EfHqp`B&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEq@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV]EfHqB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEq`FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV^EfHq`B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEqFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘBDV_EfHqdB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FAAEA FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘBDV`DHq8B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FAAEA0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘA DVXEfHq*`B"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘA0DVYES@HqzB#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘA`DVZEրHqhB$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV[ExHq B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq0FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV\EIHqێB&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqPFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV]E{Hq8B'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV_Hq>B)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1154US2021154US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7HqLLDVXHqԘHqLLHqԘDVXHqԘADV_DHqdB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADV:DHquAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtPFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HA DV;DHqDA Vaccination 1DAY 2 A DAY 2 A LOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEt`FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HA0DV@DHq]ApVaccination 1DAY 7 ApDAY 7 ApLOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HA@DVAD HqAVaccination 1DAY 8 ADAY 8 ALOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HAPDVBEeHq9PAVaccination 1DAY 9 ADAY 9 ALOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HA`DVCE>HqXlAVaccination 1DAY 10 ADAY 10ALOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADV@..ApVaccination 1DAY 7 ApDAY 7 ApLOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADVA..AVaccination 1DAY 8 ADAY 8 ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADVB..AVaccination 1DAY 9 ADAY 9 ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADVC..AVaccination 1DAY 10 ADAY 10ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADVD..AVaccination 1DAY 11 ADAY 11ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HApDV:DHquAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEs@FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADV;DHqDA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BLSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADV@DHq]ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BQSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HADVAD HqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BRSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HBDVBEHq;lAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BSSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HBDV@DHq]ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BQSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HBDVAD HqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BRSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1164US2021164US202USAB"YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqDVXHq՝HHqHq՝HDVXHq՝HBDVBEHq;lAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BSSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձADVXE@Hq2BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձA0DVYE@HqׄB Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձA@DVZE@HqՔB!Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձAPDV[E@Hq'B"Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձA`DV\E@HqxB#Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEp FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձApDV]E@HqB$Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEp@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձADV^E@HqB%Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEppFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձADV_E@HqmB&Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձADV`E@HqྔB'Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEA0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձADVaDHqlB(Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEA@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձA DVXE@Hq2BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձADV^D\Hq\B%Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp`FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1175US2021175US202USAB$YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected YNNPlacebo APlacebo ADV:HqBpDVXHqձHqBpHqձDVXHqձADV`DrHqB'Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1179US2021179US202USAB&YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV:HqLDVWHqԇHqLHqԇDVWHqԇADV?EHqGA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1179US2021179US202USAB&YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV:HqLDVWHqԇHqLHqԇDVWHqԇA DV@E@HqtApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1179US2021179US202USAB&YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV:HqLDVWHqԇHqLHqԇDVWHqԇA0DVAE@HqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1179US2021179US202USAB&YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV:HqLDVWHqԇHqLHqԇDVWHqԇA@DVBD0Hq0AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADV@..ApVaccination 1DAY 7 ApDAY 7 ApLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(A DVA..AVaccination 1DAY 8 ADAY 8 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(A0DVB..AVaccination 1DAY 9 ADAY 9 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(A@DVC..AVaccination 1DAY 10 ADAY 10ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(APDVD..AVaccination 1DAY 11 ADAY 11ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(A`DVE..AVaccination 1DAY 12 ADAY 12ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ApDVF..AVaccination 1DAY 13 ADAY 13ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVG..AVaccination 1DAY 14 ADAY 14ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVH..AVaccination 1DAY 15 ADAY 15ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVI..BVaccination 1DAY 16 BDAY 16BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVJ..BVaccination 1DAY 17 BDAY 17BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVK..BVaccination 1DAY 18 BDAY 18BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVL..BVaccination 1DAY 19 BDAY 19BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVM..BVaccination 1DAY 20 BDAY 20BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(ADVN..BVaccination 1DAY 21 BDAY 21BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDVO..BVaccination 1DAY 22 BDAY 22BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDVP..BVaccination 1DAY 23 BDAY 23BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDVQ..BVaccination 1DAY 24 BDAY 24BLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDVXEuHq+PBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDVYEuHq|B Vaccination 2DAY 2 A DAY 2 A LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDVZEuHqPB!Vaccination 2DAY 3 A0DAY 3 A0LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDV[EuHqB"Vaccination 2DAY 4 A@DAY 4 A@LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDV\EuHqqPB#Vaccination 2DAY 5 APDAY 5 APLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDV]EuHqB$Vaccination 2DAY 6 A`DAY 6 A`LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEv FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDV^EuHqPB%Vaccination 2DAY 7 ApDAY 7 ApLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEv0FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDV_EuHqeB&Vaccination 2DAY 8 ADAY 8 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDV`EuHqPB'Vaccination 2DAY 9 ADAY 9 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1180US2021180US202USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV:HqgDVXHqՐ(HqgHqՐ(DVXHqՐ(BDVaD~Hq`B(Vaccination 2DAY 10 ADAY 10ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0A DVmDHq BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0A@DVnDHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0A`DVoDHqL BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVpDHqB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVqDHq B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVrDHq@B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVsDHq B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVtDHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0BDVuDHq5 B%Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0BDVvDHqB&Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0BDVwDHq B'Vaccination 2DAY 11 ADAY 11ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0BDVxDôHqB(Vaccination 2DAY 12 ADAY 12ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVmDHq BVaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0A0DVmEHqҜBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0APDVnDHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ApDVoE@HqatBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVsEHqB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVtEHq B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0ADVuDʼHq <B%Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0BDVvDHq[B&Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1208US2021208US202USAB8YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHq̨DVmHq0Hq̨Hq0DVmHq0BDVwDtHqB'Vaccination 2DAY 11 ADAY 11ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVmDHqBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmA0DVnDHqB Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmAPDVoDHqEB!Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEp0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmApDVpDHqB"Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVqDHqB#Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEppFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVrDHq:B$Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVsDHqB%Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVtDdHqdB&Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 3/SEVERE Grade 3A0FAAEA0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmA DVmE#HqŸBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmA@DVnEHqFB Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmA`DVoEHqh|B!Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp@FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVpEHqB"Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVqEHqB#Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVrE^HqpB$Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmADVsE@Hq$B%Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmBDVPE{Hq˯A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmBDVQEp@HqA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmBDVREa@HqQA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmBDVSE@HqϤtAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmBDVTE@HqA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmBDVUEeHqEApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US202-1217US2021217US202USABBYEARS>=55 Years A >=55 Years A@FWHITE NOT REPORTED YYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVOHq DVmHqmHq HqmDVmHqmBDVVEHqӐ AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpA0DVOD Hq#B Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FACEEt`FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpAPDVPD Hqu B!Vaccination 2DAY 2 A DAY 2 A LOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpApDVQD HqƠB"Vaccination 2DAY 3 A0DAY 3 A0LOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpADVRD Hq B#Vaccination 2DAY 4 A@DAY 4 A@LOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpADVSD HqiB$Vaccination 2DAY 5 APDAY 5 APLOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpADVTD Hqл B%Vaccination 2DAY 6 A`DAY 6 A`LOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpADVUD Hq B&Vaccination 2DAY 7 ApDAY 7 ApLOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpADVVD Hq^ B'Vaccination 2DAY 8 ADAY 8 ALOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FAAEAFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpADVWDHq? B(Vaccination 2DAY 9 ADAY 9 ALOCAL APAIN Pain .GRADE 3/SEVERE Grade 3A0FAAEA FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpADVODxHqɼB Vaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEt@FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpA DVOD<HqB Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtPFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpA@DVPDHq B!Vaccination 2DAY 2 A DAY 2 A LOCAL APAIN Pain .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR INTERFERES WITH ACTIVITY Grade 2A FACEEtpFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US203-1004US2031004US203USABYEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV0HqDVOHqɮpHqHqɮpDVOHqɮpA`DVQD`Hq̕B"Vaccination 2DAY 3 A0DAY 3 A0LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADVVDHq<B!Vaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-A DVVE@HqnB!Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-A0DVWD$HqoB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-A@DVXDHqB#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-APDVYDlHq$B$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-A`DVZD$HqU$B%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ApDV[DXHqٽB&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADV\DHqB'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADV]D8HqDB(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADVWD$HqoB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADVXD$Hq$B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADVYD$HqB$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDVZD$Hqd$B%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEr FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV[D$HqٵB&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEr0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV\D$Hq$B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEr`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV]D$HqXB(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV^D$Hqݪ$B)Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV_D$HqB*Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV`D$HqM$B+Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDVaE(Hq$B,Vaccination 2DAY 12 ADAY 12ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADVWD$HqoB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADVXDHqB#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-ADVYDlHq$B$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDVZD$HqU$B%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV[DXHqٽB&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEr@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV\DHqB'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEErPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV]DHqD|B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV^DHqݻB)Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV_DHq B*Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDV`DĤHqTB+Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1042US2031042US203USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVVHq-HqHq-DVVHq-BDVaDHq@B,Vaccination 2DAY 12 ADAY 12ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVPEVHq˭`BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTA0DVQEVHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTA@DVREVHqP`BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTAPDVSEVHqϡB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTA`DVTEVHq`B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVUEVHqDB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVVEVHqӖ`B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVWEVHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVXD Hq B%Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTA DVQEHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTApDVUC@HqDB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVUEvHq&B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVWD5Hq,B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVWDtHqԗB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTADVXD͌HqьB%Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1074US2031074US203USAB4YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV4Hq}DVPHqPTHq}HqPTDVPHqPTBDVYEHqB&Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVoEHqB$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BKSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCA DVpDɐHqqB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BLSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCA0DVqEHqB&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BMSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCA@DVrE$HqMHB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BNSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCAPDVsD HqB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BOSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCA`DVtE@HqB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BPSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCApDVuDHqlB*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BQSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVvEQHqB+Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BRSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVwDHq(B,Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BSSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVxDHqB-Vaccination 2DAY 12 ADAY 12ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BTSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVyEHrB.Vaccination 2DAY 13 ADAY 13ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BUSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADV|Dm8Hr8B1Vaccination 2DAY 15 ADAY 15ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BVSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVoEHqB$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BKSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVpDɐHqqB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BLSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCADVqEHqB&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BMSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVrE$HqMHB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BNSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVsD HqB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BOSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVtE@HqB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BPSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVuDHqlB*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BQSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVvEQHqB+Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BRSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVwDHq(B,Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BSSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVxDHqB-Vaccination 2DAY 12 ADAY 12ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BTSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDVyEHrB.Vaccination 2DAY 13 ADAY 13ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BUSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1089US2031089US203USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVmHqCHqHqCDVmHqCBDV|Dm8Hr8B1Vaccination 2DAY 15 ADAY 15ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BVSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqADVlDpHqҀB!Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqA0DVmDpHq$B"Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEqFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqA@DVnDpHquB#Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEq0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqAPDVoDpHqB$Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEqPFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqApDVpDpHqB%Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEqpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqADVqDpHqjB&Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEqFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqADVrDpHqB'Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqA DVlDXHqEXB!Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqA`DVoDHq DB$Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq`FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqADVpDHqB%Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US203-1091US2031091US203USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHq(DVkHqHq(HqDVkHqADVqEHqB&Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVN..A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqA0DVO..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEopFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqA@DVP..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqAPDVQ..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqApDVR..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVS..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVT..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVU..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVV..AVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqBDVW..AVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqBDVX..AVaccination 1DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqBDVY..AVaccination 1DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqA DVNDHqȼA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEo`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqA`DVQEHqA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVRE+Hq]ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVSDHqUAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVTD(HqІ(AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqADVUEHqIAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqBDVVDHHqEHAVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqBDVXEHq0AVaccination 1DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US203-1105US2031105US203USABCYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŵDVlHqHqŵHqDVlHqBDVYE@Hqt$AVaccination 1DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVR..B Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TA0DVS..B!Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TAPDVT..B"Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TApDVU..B#Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVV..B$Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVW..B%Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVX..B&Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVY..B'Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVZ..B(Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TA DVREvHq2`B Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TA@DVSEƀHqϨB!Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TA`DVTEB@Hq$B"Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVWE.HqlB%Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1008US2041008US204USAB%YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVQHq̩THqHq̩TDVQHq̩TADVXEHqPB&Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqlDVQHqNdHqlHqNdDVQHqNdADV5..A Vaccination 1DAY 2 A DAY 2 A LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqlDVQHqNdHqlHqNdDVQHqNdA DV6..A0Vaccination 1DAY 3 A0DAY 3 A0LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqlDVQHqNdHqlHqNdDVQHqNdA0DV7..A@Vaccination 1DAY 4 A@DAY 4 A@LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqlDVQHqNdHqlHqNdDVQHqNdA@DV8..APVaccination 1DAY 5 APDAY 5 APLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqlDVQHqNdHqlHqNdDVQHqNdAPDV9..A`Vaccination 1DAY 6 A`DAY 6 A`LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEu FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqlDVQHqNdHqlHqNdDVQHqNdA`DV:..ApVaccination 1DAY 7 ApDAY 7 ApLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEu0FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US204-1060US2041060US204USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqlDVQHqNdHqlHqNdDVQHqNdApDV;..AVaccination 1DAY 8 ADAY 8 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV5DxHqfA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4A0DV6DxHqxA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4APDV7DxHq A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ApDV8DxHq[xAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV9DxHqA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV:DxHqxApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV;DxHqOAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV<DxHqxAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDV=DxHqAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDV>DHqnAVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4A DV5DhHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4A@DV6DXHqXA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4A`DV8C@HqդAPVaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV8DTHqTAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV9D8HqݸA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV:DڬHqQApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4ADV;DlHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDV<EF@HqdAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDV=DHq<AVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDV>DHqzAVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVS..B Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVT..B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVU..B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVV..B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVW..B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4B DVX..B%Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4B"DVY..B&Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4B$DVZ..B'Vaccination 2DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4B&DV[..B(Vaccination 2DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVSDxHqB Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVTDSHqB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVUDdHqsB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVUER@HqDB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVVDHqNB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4BDVWD,HqԔB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4B!DVXDHHqHB%Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4B#DVYEuHq|B&Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1073US2041073US204USAB,YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV4HqDVPHqa4HqHqa4DVPHqa4B%DVZDHqRB'Vaccination 2DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV4DHq}AVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEo FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqA0DV5DHqΐA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEo@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqAPDV6DHq A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEo`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqApDV7DHqqA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV8DHqAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV9DHqA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV:DHqfApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV;DHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV<DHq AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV=EVHqAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqA DV4DHqAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEo0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqA@DV5ELHqLA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqA`DV6DHq$A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEopFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV7E.HqlA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV8DHqAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV9DHq LA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqADV:DtHqktApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV;D$HqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV<EHqV,AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV=DHq]`AVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDVVDHq B#Vaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDVVEJHqeB#Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDVWD|HqԞB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDVXE~Hq B%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDVYDHqTB&Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDVZD(Hq؜(B'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV[E@Hq&$B(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV\EHqe B)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEppFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV]E?HqxB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV^DHqB+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDV_DHq2|B,Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB DV`DHqB-Vaccination 2DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB!DVaDHqpB.Vaccination 2DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB"DVbDxHqxB/Vaccination 2DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB#DVcDHqv$B0Vaccination 2DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB$DVeE@HqAtB2Vaccination 2DAY 16 BDAY 16BSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB%DVfEHqB3Vaccination 2DAY 17 BDAY 17BSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB&DVgDHqɀB4Vaccination 2DAY 18 BDAY 18BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB'DVhDְHqB5Vaccination 2DAY 19 BDAY 19BSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB(DViDHq:B6Vaccination 2DAY 20 BDAY 20BSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB)DV5..A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB+DV6..A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB,DV7..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB-DV8..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB/DV9..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB1DV:..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB3DV;..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB5DV<..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB7DV=..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB9DV>..AVaccination 1DAY 11 ADAY 11ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB*DV5ELHqLA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB.DV8DHqAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB0DV9DHq LA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB2DV:DtHqktApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB4DV;DHqhAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB6DV<EHqV,AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB8DV=DHq]`AVaccination 1DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB;DVVDHqB#Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB=DVWDHqpXB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB?DVXDHqB%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBADVYDHqXB&Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBBDVZDHqdB'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBDDV[DHqٶXB(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBFDV\DHqB)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEr0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBHDV]DHqYXB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBJDV^DHqݪB+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEB!FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBLDV_..B,Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEB#FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB:DVVDHq B#Vaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB<DVVEJHqeB#Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB>DVWD|HqԞB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB@DVXE~Hq B%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBCDVZD(Hq؜(B'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBEDV[E@Hq&$B(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEr FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBGDV\EHqe B)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEr@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBIDV]E?HqxB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBKDV^DHqB+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB"FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBNDVVDHqB#Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBPDVWDHqpXB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBRDVXDHqB%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEs FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBTDVYDHqXB&Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEs@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBVDVZDHqdB'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEs`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBXDV[DHqٶXB(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBZDV\DHqB)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB\DV]DHqYXB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEB%FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB^DV^DHqݪB+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEB'FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBMDVVDHq B#Vaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBODVVEJHqeB#Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBQDVWD|HqԞB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBSDVXE~Hq B%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEs0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBUDVYDHqTB&Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBWDVZD(Hq؜(B'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEspFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqBYDV[E@Hq&$B(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB[DV\EHqe B)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1076US2041076US204USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV4Hq6 DVVHqHq6 HqDVVHqB]DV]E?HqxB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB&FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVO..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDA0DVP..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDAPDVQ..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDApDVR..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVS..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVT..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDA DVOEHqvA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDA@DVPEYHq}APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDA`DVQE@HqҔA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVSEHq}AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVQEHqXA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVSEHq}AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVQEHqXA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US204-1126US2041126US204USAB>YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqDHqLHqDDVlHqDADVSEHq}AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVrEHqK,BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdA@DVsEHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdAPDVtEHq,BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdApDVuEHq?B Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVvEHq,B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVwEHqB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVxEHr4,B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdBDVyEHrB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdBDVzDHrB%Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdA DVrEHqK,BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdA0DVsD0HqzBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdA`DVtEHqPBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVuEHqhB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVvE<HqB!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVwEHqpB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVyDOtHrB$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US204-1155US2041155US204USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYNYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVVHq;DVrHqdHq;HqdDVrHqdADVyDHr>lB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADVW..B"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBA0DVX..B#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBAPDVY..B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEmFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBApDVZ..B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEmFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADV[..B&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEn FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADV\..B'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEn0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADV]..B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FACEEn`FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADV^..B)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADV_..B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .GRADE 3/SEVERE Grade 3A0FAAEA FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBA DVXD9lHq=lB#Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBA@DVYDHq\B$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBA`DVZD4Hq'4B%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADVZD܌Hq؃B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECTY Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADV\EHqۋB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnPFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBADVW..B"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDVX..B#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDVY..B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDVZ..B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV[..B&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV\..B'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV]..B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV^..B)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV_..B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDVXD9lHq=lB#Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDVYDHq\B$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDVZD4Hq'4B%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEppFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDVZD܌Hq؃B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV\DHqΨB'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV\EHqۋB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV]ED@HqܿB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBBDV^EHq B)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1033US2051033US205USAB(YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYNYYNNYYYYYYNYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6Hq DVWHqBHq HqBDVWHqBB DV_DpHq'B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐA DVhDHqꨠBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐA@DViDHq BVaccination 2DAY 2 A DAY 2 A LOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐA`DVjDHqKBVaccination 2DAY 3 A0DAY 3 A0LOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVkDHq B Vaccination 2DAY 4 A@DAY 4 A@LOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FACEEv FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVlDHqB!Vaccination 2DAY 5 APDAY 5 APLOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FACEEv@FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVmDHq@ B"Vaccination 2DAY 6 A`DAY 6 A`LOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FACEEv`FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVnDHqB#Vaccination 2DAY 7 ApDAY 7 ApLOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVoDHq B$Vaccination 2DAY 8 ADAY 8 ALOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FAAEBFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVpDHq4B%Vaccination 2DAY 9 ADAY 9 ALOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FAAEB FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVqDHq B&Vaccination 2DAY 10 ADAY 10ALOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FAAEB!FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVrDHqנB'Vaccination 2DAY 11 ADAY 11ALOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FAAEB#FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVsDHq) B(Vaccination 2DAY 12 ADAY 12ALOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FAAEB%FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVtHqB)Vaccination 2DAY 13 ADAY 13ALOCAL APAIN Pain .GRADE 2/MODERATE Grade 2A FAAEB'FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVhDdHqdBVaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEuFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐA0DVhDHqڌBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEuFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐAPDViDHq@BVaccination 2DAY 2 A DAY 2 A LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEuFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐApDVjDHqiBVaccination 2DAY 3 A0DAY 3 A0LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEvFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVkDôHq4B Vaccination 2DAY 4 A@DAY 4 A@LOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEv0FASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVlD(Hq (B!Vaccination 2DAY 5 APDAY 5 APLOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEvPFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐADVnDHqB#Vaccination 2DAY 7 ApDAY 7 ApLOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEvFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVoDHqB$Vaccination 2DAY 8 ADAY 8 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVqDʼHq<B&Vaccination 2DAY 10 ADAY 10ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEB"FASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVrDHq7B'Vaccination 2DAY 11 ADAY 11ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEB$FASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVsDHqHB(Vaccination 2DAY 12 ADAY 12ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEB&FASTRESC STUDY SUBJECT Y YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVL..AVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVM..A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVN..A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB DVO..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB"DVP..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB$DVQ..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB&DVR..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB(DVS..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB*DVT..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB,DVU..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB.DVV..AVaccination 1DAY 11 ADAY 11ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVLDHqAVaccination 1DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVLDHqAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVMDxHq7A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDVNDHqȂA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB!DVODpHqA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB#DVPDHHqMHAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB%DVQDHqw,A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB'DVSDRHqξAVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB)DVSDHq4lAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB+DVTDHqlAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB-DVVDV|Hqҷ|AVaccination 1DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB/DVL..AVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB1DVM..A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB3DVN..A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB5DVO..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB7DVP..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEppFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB9DVQ..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB;DVR..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB=DVS..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB?DVT..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBADVU..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBCDVV..AVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBEDVW..AVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBGDVX..AVaccination 1DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB0DVLDHqAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB2DVMDxHq7A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB4DVNDHqȂA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB6DVODpHqA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB8DVPDHHqMHAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB:DVQDHqw,A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB<DVSDRHqξAVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB>DVSDHq4lAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB@DVTD`Hql`AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBBDVVDV|Hqҷ|AVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBDDVVDHq AVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBFDVWDHqbHAVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBHDVh..BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBJDVi..BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBLDVj..BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEq FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBNDVk..B Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEq@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBPDVl..B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEq`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBRDVm..B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBTDVn..B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBVDVo..B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBIDVhDHqڌBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBKDViDHq|BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBMDVjDHqiBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBODVkDHqpB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBQDVlD(Hq (B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBSDVnD,Hq,B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBUDVnDHqB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBWDVoDHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBYDVh..BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEs@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB[DVi..BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEspFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB]DVj..BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB_DVk..B Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBaDVl..B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBcDVm..B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBeDVn..B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBgDVo..B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBXDVhDHqꨠBVaccination 2DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBZDVhDHqڌBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEs`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB\DViDHq|BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB^DVjDHqiBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐB`DVkDHqpB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBbDVlD(Hq (B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBdDVnD,Hq,B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBfDVnDHqB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEt FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1057US2051057US205USAB=YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVLHqŹDVhHqꚐHqŹHqꚐDVhHqꚐBhDVoDHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVlEHqsBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqA0DVmEHq@BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqAPDVnEHqBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqApDVoEHqh@B Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVpEHqB!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVqEHq @B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVrEHq\B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVsEɀHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqA DVlEHqsBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqA@DVmEHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqA`DVnE@HqBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVoEHqtB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVpE@HqtB!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVqEHqB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqADVrE*HqmB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVsEɀHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVlEHqsBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVmEHq@BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVnEHqBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVoEHqh@B Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEppFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVpEHqB!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVqEHq @B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVrEHq\B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB DVsEHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVlEHqsBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVmEHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVnE@HqBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVoEHqtB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVpE@HqtB!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVqEHqB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVrE*HqmB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqBDVsEHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB"DVmEHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB$DVnEHqC BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB&DVoEHqB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB(DVpEHq B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB*DVqEHq7B"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEs FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB,DVrEHq B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEs@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB-DVsEɀHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB!DVmEHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB#DVnE@HqBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB%DVoEHqtB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB'DVpE@HqtB!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB)DVqEHqB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEsFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB+DVrE*HqmB#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEs0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1068US2051068US205USABDYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVPHq:DVlHqHq:HqDVlHqB.DVsEɀHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqADVMHqƃA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqA0DVNHqA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqA@DVOHq&A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqAPDVPHqxAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqA`DVQHqɀA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqApDVRHqApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqADVSHqlAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqA DVMDHqB A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqADVREwHqR|ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEppFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US205-1069US2051069US205USAB@YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqLDVlHqHqLHqDVlHqADVSEtHqϣAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADVVEHqz@B"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqA0DVWEHqB#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqAPDVXEHq@B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqApDVYEHqnB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADVZEHq@B&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADV[EHqB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADV\EHqc@B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADV]EHqܴB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDV^EHq@B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDV_EHqWB+Vaccination 2DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDV`EHq@B,Vaccination 2DAY 11 ADAY 11ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVaEHqB-Vaccination 2DAY 12 ADAY 12ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVbEHqL@B.Vaccination 2DAY 13 ADAY 13ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVcEHqB/Vaccination 2DAY 14 ADAY 14ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVdEHq@B0Vaccination 2DAY 15 ADAY 15ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVeEHq@B1Vaccination 2DAY 16 BDAY 16BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB!DVfEHq@B2Vaccination 2DAY 17 BDAY 17BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB#DVgEHqB3Vaccination 2DAY 18 BDAY 18BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB%DVhEHq5@B4Vaccination 2DAY 19 BDAY 19BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB'DViEHqB5Vaccination 2DAY 20 BDAY 20BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB)DVjEHq@B6Vaccination 2DAY 21 BDAY 21BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB+DVkEHq)B7Vaccination 2DAY 22 BDAY 22BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB-DVlEHq{@B8Vaccination 2DAY 23 BDAY 23BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB/DVmEHqB9Vaccination 2DAY 24 BDAY 24BSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEB!FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqA DVVEHqӍB"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqA@DVWE)HqB#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqA`DVXEwHq;|B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADVYEfHq{B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEn FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADVZEHq B&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEn@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADV[EHq1B'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqADV\EHqۃB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDV]E@HqtB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDV^EHq6B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDV_EHq|B+Vaccination 2DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVaDT`Hq5B-Vaccination 2DAY 11 ADAY 11ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVbD$Hq$B.Vaccination 2DAY 12 ADAY 12ASYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVcDHq|B/Vaccination 2DAY 13 ADAY 13ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVcE@Hq4B/Vaccination 2DAY 14 ADAY 14ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqBDVdEHq\B0Vaccination 2DAY 15 ADAY 15ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB DVeEp@Hq^B1Vaccination 2DAY 16 BDAY 16BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB"DVgDnHq9\B3Vaccination 2DAY 17 BDAY 17BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB$DVgEHqB3Vaccination 2DAY 18 BDAY 18BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB&DViDr$HqߤB5Vaccination 2DAY 19 BDAY 19BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB(DViE(HqB5Vaccination 2DAY 20 BDAY 20BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB*DVjEwHq|B6Vaccination 2DAY 21 BDAY 21BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB,DVlDDHqDB8Vaccination 2DAY 22 BDAY 22BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB.DVlEHqB8Vaccination 2DAY 23 BDAY 23BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB0DVmEHqB9Vaccination 2DAY 24 BDAY 24BSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB"FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB4DV\DT`Hqڞ`B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB6DV]DT`HqB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEB$FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB8DV^DbpHqOpB*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEB&FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB1DVWE)HqB#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEr0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB2DVYEfHq{B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB3DVZEHq B&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEr`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB5DV\EHqۃB(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1008US2061008US206USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV5Hq<DVVHqHq<HqDVVHqB7DV]EHqӰB)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB%FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$A@DV9..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$A`DV:..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ApDV;..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV<..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV5E@HqtAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEo FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$A DV6E'@HqCtA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEo0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$A0DV7EvHqA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEo@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$APDV9DHqlAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEopFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV<DsHqAVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV<ExHqAAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV;..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 3/SEVERE Grade 3A0FACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV9DHqlAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV;DhHqApVaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .ANY USE OF PRESCRIPTION PAIN RELIEVER OR PREVENTS DAILY ACTIVITY Grade 3A0FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV<DsHqAVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US206-1015US2061015US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVVHq-$HqHq-$DVVHq-$ADV<ExHqAAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .ANY USE OF PRESCRIPTION PAIN RELIEVER OR PREVENTS DAILY ACTIVITY Grade 3A0FAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV<DHqA`Vaccination 1DAY 6 A`DAY 6 A`LOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqA DV=E@HqApVaccination 1DAY 7 ApDAY 7 ApLOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqA0DV>DHqAVaccination 1DAY 8 ADAY 8 ALOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqAPDV<..A`Vaccination 1DAY 6 A`DAY 6 A`LOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqA`DV=..ApVaccination 1DAY 7 ApDAY 7 ApLOCAL APAIN Pain .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqApDV>..AVaccination 1DAY 8 ADAY 8 ALOCAL APAIN Pain .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY YYY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqA@DV8Dj,Hq>,A Vaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL APAIN Pain .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEs@FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV\..B&Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV]..B'Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV^..B(Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV_..B)Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqBDV`..B*Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqBDVa..B+Vaccination 2DAY 12 ADAY 12ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqBDVb..B,Vaccination 2DAY 13 ADAY 13ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV]C0Hq۞B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEr FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV^DlHHqYHB(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV^Es@Hq4B(Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqADV`Dv Hq B*Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqBDVaD2(HqB+Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1023US2061023US206USABYEARS>=18 and <55 YearsA>=18 and <=22 YearsAFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV7Hq%DVVHqHq%HqDVVHqBDVaE@Hq2B+Vaccination 2DAY 12 ADAY 12ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVlDHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(A0DVmDHqN0BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(APDVnDHqB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ApDVoDHq0B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVpDHqBB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVqDHq0B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVrD HqH B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(A DVlEIHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(A@DVmEHqBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(A`DVoD/HqB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVoEHq0B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVqDRHqLB#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVrDCDHqDB$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVrEHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(ADVtDjHqXB&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVuCxHqGB'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVlDHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVmDHqN0BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVnDHqB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVoDHq0B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEppFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVpDHqBB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVqDHq0B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVrD HqH B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVlEIHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVoD/HqB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVqDRHqLB#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVrDCDHqDB$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVrEHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVlDHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVmDHqN0BVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B!DVnDHqB Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B#DVoDHq0B!Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B$DVpDHqBB"Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B%DVqDHq0B#Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEEsFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B'DVrD HqH B$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(BDVlEIHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B DVmEHqBVaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B"DVoD/HqB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B&DVrDCDHqDB$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEs FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US206-1043US2061043US206USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVOHqDVkHq(HqHq(DVkHq(B(DVrEHqB$Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVP..BVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEv`FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:A DVQ..BVaccination 2DAY 2 A DAY 2 A LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvpFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:A@DVR..B Vaccination 2DAY 3 A0DAY 3 A0LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:A`DVS..B!Vaccination 2DAY 4 A@DAY 4 A@LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ApDVT..B"Vaccination 2DAY 5 APDAY 5 APLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVU..B#Vaccination 2DAY 6 A`DAY 6 A`LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVV..B$Vaccination 2DAY 7 ApDAY 7 ApLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEvFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVW..B%Vaccination 2DAY 8 ADAY 8 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEBXFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:A0DVQEeHqBVaccination 2DAY 2 A DAY 2 A LOCAL ASWELLDIASwelling Longest Diameter (mm) B#35 Grade 1AFACEEj`FASTRESC STUDY SUBJECTYY YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:APDVREHqKB Vaccination 2DAY 3 A0DAY 3 A0LOCAL ASWELLDIASwelling Longest Diameter (mm) B30 Grade 1AFACEEjpFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVQDpHq:BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn`FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVRDpHq͋B Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVSDpHqB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVTDpHq.B"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVUDpHqрB#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVVDpHqрB$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVWDpHq#B%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVXDpHqtB&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVQEhHq BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEnpFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ADVREHqL(B Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVSEHqϛB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVTEHqB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVUEHq?@B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVVEHqӐ B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVR..B Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVS..B!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVT..B"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B!DVU..B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEq0FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B#DVV..B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEqPFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B%DVW..B%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B'DVX..B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B)DVY..B'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B+DVZ..B(Vaccination 2DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B-DV[..B)Vaccination 2DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B/DV\..B*Vaccination 2DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B1DV]..B+Vaccination 2DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B3DV^..B,Vaccination 2DAY 15 ADAY 15ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B5DV_..B-Vaccination 2DAY 16 BDAY 16BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B7DV`..B.Vaccination 2DAY 17 BDAY 17BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B9DVa..B/Vaccination 2DAY 18 BDAY 18BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B;DVb..B0Vaccination 2DAY 19 BDAY 19BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B=DVc..B1Vaccination 2DAY 20 BDAY 20BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B?DVd..B2Vaccination 2DAY 21 BDAY 21BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB!FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BADVe..B3Vaccination 2DAY 22 BDAY 22BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB#FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BCDVf..B4Vaccination 2DAY 23 BDAY 23BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB$FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BEDVg..B5Vaccination 2DAY 24 BDAY 24BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB'FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BGDVh..B6Vaccination 2DAY 25 BDAY 25BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB)FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BIDVi..B7Vaccination 2DAY 26 BDAY 26BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB+FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BKDVj..B8Vaccination 2DAY 27 BDAY 27BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB-FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BMDVk..B9Vaccination 2DAY 28 BDAY 28BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB/FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BODVl..B:Vaccination 2DAY 29 BDAY 29BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB1FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BQDVm..B;Vaccination 2DAY 30 BDAY 30BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB2FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BSDVn..B<Vaccination 2DAY 31 BDAY 31BSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB5FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BUDVo..B=Vaccination 2DAY 32 B DAY 32B SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB7FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BWDVp..B>Vaccination 2DAY 33 B!DAY 33B!SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB8FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BYDVq..B?Vaccination 2DAY 34 B"DAY 34B"SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB;FASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVPEHq˧HBVaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVQEhHq BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVREHqL(B Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .SIGNIFICANT; PREVENTS DAILY ACTIVITY Grade 3A0FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVSEHqϛB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B DVTEHqB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B"DVUEHq?@B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B$DVVEHqӐ B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq`FASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B&DVWEHqPB%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B(DVXEmHq*B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B*DVYEiHq|B'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEAFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B,DV[HqB)Vaccination 2DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B.DV[EHq* B)Vaccination 2DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B0DV\EHqw,B*Vaccination 2DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B2DV]EHqܹpB+Vaccination 2DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B4DV^E@HqB,Vaccination 2DAY 15 ADAY 15ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B6DV_EHqZB-Vaccination 2DAY 16 BDAY 16BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B8DV`ED@HqDB.Vaccination 2DAY 17 BDAY 17BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B:DVaE@HqB/Vaccination 2DAY 18 BDAY 18BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B<DVbEHq[|B0Vaccination 2DAY 19 BDAY 19BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B>DVcEHqlB1Vaccination 2DAY 20 BDAY 20BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B@DVdE HqB2Vaccination 2DAY 21 BDAY 21BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB"FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BBDVfDJHqÈB4Vaccination 2DAY 22 BDAY 22BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB%FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDDVfEHq8B4Vaccination 2DAY 23 BDAY 23BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB&FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BFDVgE+Hq <B5Vaccination 2DAY 24 BDAY 24BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB(FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BHDVhE,HqNB6Vaccination 2DAY 25 BDAY 25BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB*FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BJDViE@HqB7Vaccination 2DAY 26 BDAY 26BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB,FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BLDVjE/HqB8Vaccination 2DAY 27 BDAY 27BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB.FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BNDVkE@HqaB9Vaccination 2DAY 28 BDAY 28BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BPDVmC)@HqB;Vaccination 2DAY 29 BDAY 29BSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB3FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BRDVmE@HqB;Vaccination 2DAY 30 BDAY 30BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB4FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BTDVnE@HqNB<Vaccination 2DAY 31 BDAY 31BSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEB6FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BVDVpDxxHq xB>Vaccination 2DAY 32 B DAY 32B SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB9FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BXDVpEHq,B>Vaccination 2DAY 33 B!DAY 33B!SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB:FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BZDVQEHqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B\DVREHq4@B Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEr0FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B^DVSEHqυB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEErPFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B`DVTEHq@B"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEErpFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BbDVUEHq(B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BdDVVEHqz@B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BfDVWEHqB%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEB>FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BhDVXEHq@B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEB@FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BjDVYEHqnB'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBBFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BlDVZEHq@B(Vaccination 2DAY 11 ADAY 11ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBDFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BnDV[EHqB)Vaccination 2DAY 12 ADAY 12ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBFFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BpDV\DpHqںB*Vaccination 2DAY 13 ADAY 13ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEBHFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B[DVQEhHq BVaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEr FASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B]DVREHqL(B Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEr@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B_DVSEHqϛB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEr`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BaDVTEHqB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BcDVUEHq?@B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BeDVVEHqӐ B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEErFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BgDVWEHqPB%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEB?FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BiDVXEmHq*B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BkDVYEiHq|B'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBCFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BmDV[HqB)Vaccination 2DAY 11 ADAY 11ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBEFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BoDV[EHq* B)Vaccination 2DAY 12 ADAY 12ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBGFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BqDV\EHqw,B*Vaccination 2DAY 13 ADAY 13ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBIFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BrDV]EHqܹpB+Vaccination 2DAY 14 ADAY 14ASYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERERENCE WITH ACTIVITYGrade 2A FAAEBJFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BsDV^E@HqB,Vaccination 2DAY 15 ADAY 15ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBKFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BtDV_EHqZB-Vaccination 2DAY 16 BDAY 16BSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBLFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BuDV`ED@HqDB.Vaccination 2DAY 17 BDAY 17BSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBMFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BvDVaE@HqB/Vaccination 2DAY 18 BDAY 18BSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBNFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BwDVbEHq[|B0Vaccination 2DAY 19 BDAY 19BSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBOFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BxDVQE@HqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS B@SUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:ByDVREHqKB Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BASUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BzDVSEHqϛB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BBSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B{DVTE@HqB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BCSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B|DVUE@Hq?B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BDSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B}DVVE@HqӏB$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BESUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:B~DVWE@HqB%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVXEmHq*B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVYEfHq{B'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDV[HqB)Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BISUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVQE@HqBVaccination 2DAY 2 A DAY 2 A SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS B@SUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVREHqKB Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BASUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVSEHqϛB!Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BBSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVTE@HqB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BCSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVUE@Hq?B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BDSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVVE@HqӏB$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BESUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVWE@HqB%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVXEmHq*B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVYEfHq{B'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDV[HqB)Vaccination 2DAY 11 ADAY 11ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BISUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVT..B"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVU..B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 1/MILD Grade 1AFACEEu FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVV..B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 1/MILD Grade 1AFACEEu@FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVW..B%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 1/MILD Grade 1AFAAEBRFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVX..B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 1/MILD Grade 1AFAAEBTFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVY..B'Vaccination 2DAY 10 ADAY 10ASYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 1/MILD Grade 1AFAAEBVFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVTEHqB"Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEuFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVUEHq?@B#Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEu0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVVEHqӐ B$Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEuPFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVWEHqB%Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFAAEBSFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1002US2071002US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DV3HqDVPHq:HqHq:DVPHq:BDVXEmHq*B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFAAEBUFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADVY..B$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆA0DVZ..B%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆA@DV[..B&Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆAPDV\..B'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆA`DV]..B(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp0FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADV^..B)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpPFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADV_..B*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADV`..B+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA0FASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆA DVYEmHq|XB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆApDV]EHqܹpB(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADV^E@HqB)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADV_EHq\pB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA FASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADV`ED@HqDB+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADVaEHqPB,Vaccination 2DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆADVbE@HqlB-Vaccination 2DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDVcE"Hq䦨B.Vaccination 2DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDVdED@HqDB/Vaccination 2DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDVfDdHq݌B1Vaccination 2DAY 14 ADAY 14ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDVYDpHqB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDVZDpHqB%Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq0FASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV[DpHqiB&Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqPFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV\DpHqںB'Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqpFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV]DpHq B(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV^DpHq]B)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV_DpHqޯB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV`..B+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDVYEmHq|XB$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV]EHqܹpB(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV^E@HqB)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV_E@Hq\4B*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECTY YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆBDV`ED@HqDB+Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB DVaE@HqB,Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB!DVbE@HqlB-Vaccination 2DAY 11 ADAY 11ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB"DVcE"Hq䦨B.Vaccination 2DAY 12 ADAY 12ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB#DVdE@HqB/Vaccination 2DAY 13 ADAY 13ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB$DVfDdHq݌B1Vaccination 2DAY 14 ADAY 14ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB%DVYEiHq|B$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BQSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB&DV]EHqܹpB(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BUSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB'DV^ED@HqDB)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BVSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB(DV_E@Hq\4B*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BWSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB)DVYEiHq|B$Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BQSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB*DV]EHqܹpB(Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BUSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB+DV^ED@HqDB)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BVSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB,DV_E@Hq\4B*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BWSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB-DV^..B)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFACEErFASTRESC INVESTIGATOR Y Y mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB/DV_..B*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A MYALGIA Myalgia .GRADE 1/MILD Grade 1AFAAEBFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1004US2071004US207USAB'YEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DV6HqDVXHqՆHqHqՆDVXHqՆB.DV^E@HqB)Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A MYALGIA Myalgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEErFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1022US2071022US207USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVRHqʹHqHqʹDVRHqʹADV;..ApVaccination 1DAY 7 ApDAY 7 ApLOCAL ALYMPH Axillary Swelling or Tenderness .GRADE 1/MILD Grade 1AFACEEtFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1022US2071022US207USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVRHqʹHqHqʹDVRHqʹA0DV<..AVaccination 1DAY 8 ADAY 8 ALOCAL ALYMPH Axillary Swelling or Tenderness .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US207-1022US2071022US207USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVRHqʹHqHqʹDVRHqʹA DV;DHq@ApVaccination 1DAY 7 ApDAY 7 ApLOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEtFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1022US2071022US207USABYEARS>=18 and <55 YearsA>25 and <55 Years A0MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV5HqDVRHqʹHqHqʹDVRHqʹA@DV<DHqAVaccination 1DAY 8 ADAY 8 ALOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US207-1085US2071085US207USABKYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVlHq)tHqHq)tDVlHq)tADVODHq!A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1085US2071085US207USABKYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVlHq)tHqHq)tDVlHq)tA DVRDHqApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1085US2071085US207USABKYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVlHq)tHqHq)tDVlHq)tA0DVSDTHqbAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1085US2071085US207USABKYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVlHq)tHqHq)tDVlHq)tA@DVTEHq\AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1085US2071085US207USABKYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVLHqDVlHq)tHqHq)tDVlHq)tAPDVUDHq AVaccination 1DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1100US2071100US207USAB=YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqC,DVsHq4$HqC,Hq4$DVsHq4$ADVyDW0HrܰB$Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1100US2071100US207USAB=YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqC,DVsHq4$HqC,Hq4$DVsHq4$A DVzD[Hr2B%Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1100US2071100US207USAB=YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqC,DVsHq4$HqC,Hq4$DVsHq4$A0DV{DSHr|,B&Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1100US2071100US207USAB=YEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqC,DVsHq4$HqC,Hq4$DVsHq4$A@DV{ExHrP B&Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV[DHqhA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dA DV\DHqAApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dA0DV^DPdHq=dAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dA@DV^EHq(AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BISUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dAPDV_E(@HqAAVaccination 1DAY 10 ADAY 10ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BJSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dA`DV[DHqhA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dApDV\DHqAApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV^DPdHq=dAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV^EHq(AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BISUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV_E(@HqAAVaccination 1DAY 10 ADAY 10ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BJSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV[DHqhA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV\DHqAApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV^DPdHq=dAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV^EHq(AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BISUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US207-1105US2071105US207USABAYEARS>=55 Years A >=55 Years A@MWHITE NOT HISPANIC OR LATINOYYYNYNYYYNNNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADVVHqDVyHr(dHqHr(dDVyHr(dADV_E(@HqAAVaccination 1DAY 10 ADAY 10ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BJSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV<..A`Vaccination 1DAY 6 A`DAY 6 A`LOCAL ALYMPH Axillary Swelling or Tenderness .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR YY YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTA0DV=..ApVaccination 1DAY 7 ApDAY 7 ApLOCAL ALYMPH Axillary Swelling or Tenderness .GRADE 1/MILD Grade 1AFACEEu FASTRESC INVESTIGATOR YY YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTAPDV>..AVaccination 1DAY 8 ADAY 8 ALOCAL ALYMPH Axillary Swelling or Tenderness .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR YY YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTA DV<E$HqHA`Vaccination 1DAY 6 A`DAY 6 A`LOCAL ALYMPH Axillary Swelling or Tenderness .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR INTERFERES WITH SOME ACTIVITY Grade 2A FACEEuFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTA@DV=EHq|ApVaccination 1DAY 7 ApDAY 7 ApLOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFACEEu0FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTA`DV>DŔHqAVaccination 1DAY 8 ADAY 8 ALOCAL ALYMPH Axillary Swelling or Tenderness .DOES NOT INTERFERE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTApDV8..A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEo`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV9..A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV:..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV;..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV<..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTBDV=..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTBDV>..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV8DlHqlA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEopFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV9DHq<A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV:DHqvA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTADV;ExHq APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTBDV<E(@HqA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTBDV=EHq|ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1057US2081057US208USAB-YEARS>=18 and <55 YearsA>25 and <55 Years A0FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNPlacebo APlacebo ADV7HqCDVYHqTHqCHqTDVYHqTBDV>DŔHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVL..AVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqA0DVM..A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqAPDVN..A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqA`DVO..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVP..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVQ..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEp`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVR..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVS..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEB%FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqA DVLEHq@AVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqA@DVMDHqXPA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqApDVODHqxA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVPDHq]APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVQDڬHq̤,A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEppFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVREGHqOpApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1069US2081069US208USABFYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqDVhHqHqHqDVhHqADVSEHqϗAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEB&FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqADVt..B$Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEu@FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqA DVu..B%Vaccination 2DAY 2 A DAY 2 A LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuPFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqA@DVv..B&Vaccination 2DAY 3 A0DAY 3 A0LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEu`FASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqA`DVw..B'Vaccination 2DAY 4 A@DAY 4 A@LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEupFASTRESC INVESTIGATOR Y YY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqADVx..B(Vaccination 2DAY 5 APDAY 5 APLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqADVy..B)Vaccination 2DAY 6 A`DAY 6 A`LOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqADVz..B*Vaccination 2DAY 7 ApDAY 7 ApLOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFACEEuFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqADV{..B+Vaccination 2DAY 8 ADAY 8 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqADV|..B,Vaccination 2DAY 9 ADAY 9 ALOCAL ASWELLDIASwelling Longest Diameter (mm) .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqA0DVuDшHqB%Vaccination 2DAY 2 A DAY 2 A LOCAL ASWELLDIASwelling Longest Diameter (mm) B(40 Grade 1AFACEEj`FASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqAPDVvEHq,B&Vaccination 2DAY 3 A0DAY 3 A0LOCAL ASWELLDIASwelling Longest Diameter (mm) BP80 Grade 2A FACEEjpFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1076US2081076US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVQHqV DVtHqHqV HqDVtHqApDVwDXHqB'Vaccination 2DAY 4 A@DAY 4 A@LOCAL ASWELLDIASwelling Longest Diameter (mm) B#35 Grade 1AFACEEjFASTRESC STUDY SUBJECT Y YYY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVR..AVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqA0DVS..A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEo@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqAPDVT..A0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEo`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqApDVU..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVV..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVW..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVX..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVY..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDVZ..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV[..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV\..AVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV]..AVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV^..AVaccination 1DAY 13 ADAY 13ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqA DVRDHqAVaccination 1DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEo0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqA@DVSDHqcLA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqA`DVTDHqТA0Vaccination 1DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEopFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVVDHqLAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVWDHqԛ<A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVXDXHqXApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqADVYDHqOAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV[DHqٳLAVaccination 1DAY 10 ADAY 10ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV\DHq AVaccination 1DAY 11 ADAY 11ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV^DpHq]AVaccination 1DAY 12 ADAY 12ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDVVDHqLAPVaccination 1DAY 5 APDAY 5 APSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEk`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDVWDHqԛ<A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDVXDXHqXApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A RASHOCC Rash Occurrence .Y .FACEEkFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDVYDHqOAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1092US2081092US208USABMYEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqͭDVoHqHqͭHqDVoHqBDV[DHqٳLAVaccination 1DAY 10 ADAY 10ASYSTEMIC A RASHOCC Rash Occurrence .Y .FAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVm..B"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$A0DVn..B#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$APDVo..B$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEmFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ApDVp..B%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVq..B&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEn0FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVr..B'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVs..B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFACEEnpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVt..B)Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVu..B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEA FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVv..B+Vaccination 2DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVw..B,Vaccination 2DAY 11 ADAY 11ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEApFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVx..B-Vaccination 2DAY 12 ADAY 12ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVy..B.Vaccination 2DAY 13 ADAY 13ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVz..B/Vaccination 2DAY 14 ADAY 14ASYSTEMIC A ARTHRALGArthralgia .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$A DVmEhHqB"Vaccination 2DAY 1, AFTER VACCINATION (AT HOME) A333333DAY 1 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$A@DVnEHqhB#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A ARTHRALGArthralgia .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEmFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$A`DVoDHqTB$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVpE@HqԴB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVqD@HqB&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVrDHqFB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEn`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$ADVsDHq8B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEnFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVuDJHqB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVuE#HqQB*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVvEHqB+Vaccination 2DAY 10 ADAY 10ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVwEHqB,Vaccination 2DAY 11 ADAY 11ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVxEuHr[PB-Vaccination 2DAY 12 ADAY 12ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVzDHrB/Vaccination 2DAY 14 ADAY 14ASYSTEMIC A ARTHRALGArthralgia .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVnEHqhB#Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVoDHqTB$Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVpE@HqԴB%Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$BDVqD@HqB&Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$B DVrDHqFB'Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$B!DVsDHq8B(Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$B"DVuDIHqTB*Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$B#DVuEHqQ|B*Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1099US2081099US208USAB7YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYNNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVLHqŮ8DVmHq$HqŮ8Hq$DVmHq$B$DVvEHqB+Vaccination 2DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEBFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqA DVU..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqA@DVV..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqA`DVW..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVX..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVY..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVSDHq\A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqA0DVUDdHqѹA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqAPDVVDHq APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqApDVWDHq\lA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVXDHqխApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVYDHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVt..B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVu..B$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEppFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVv..B%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVw..B&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVx..B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVy..B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVz..B)Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .GRADE 1/MILD Grade 1AFAAEA`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVtDdHqdB#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqADVuDTHqB$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVxDHqB'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVyDHr5HB(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVzDHrB)Vaccination 2DAY 9 ADAY 9 ASYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEApFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVU..A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq@FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVV..APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEq`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVW..A`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVX..ApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFACEEqFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqB!DVY..AVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqB#DVZ..AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqB%DV[..AVaccination 1DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .GRADE 1/MILD Grade 1AFAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVSDHq\A Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVUDdHqѹA@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVVDHq APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqBDVWDHq\lA`Vaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqB DVXDHqխApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqB"DVYDTHqAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqB$DVZDHqVAVaccination 1DAY 9 ADAY 9 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1100US2081100US208USAB;YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYNYNYNYNNNYYYYYYNYNYYYNNot Detected NNNmRNA-1273 50 ug A mRNA-1273 50 ug A DVRHqDVrHqHqHqDVrHqB&DV[DHq١|AVaccination 1DAY 10 ADAY 10ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADVVD Hq AVaccination 1DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS B;SUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<A DVWEHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS B=SUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<A0DVYEHq}A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS B?SUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<A@DVZEHq|APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS B@SUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<APDV\DHqApVaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BASUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<A`DV\EǀHqvxApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BBSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ApDV]EHqܤAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BCSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADV_DpHqޯ<AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BDSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADV_EmHqeXAVaccination 1DAY 10 ADAY 10ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BESUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADV`EKHq഼AVaccination 1DAY 11 ADAY 11ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADVaES@HqAVaccination 1DAY 12 ADAY 12ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADVbEHqd(AVaccination 1DAY 13 ADAY 13ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADVcEHqĨAVaccination 1DAY 14 ADAY 14ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BISUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADVdEHqAVaccination 1DAY 15 ADAY 15ASYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BJSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<ADVeEHqfBVaccination 1DAY 16 BDAY 16BSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BKSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVfEq@HqBVaccination 1DAY 17 BDAY 17BSYSTEMIC A MEDTAK Medication Taken Today for Pain or Fever .Y .VS BLSUPPVS.QVAL where QNAM='MEDTAK' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVVD Hq AVaccination 1DAY 1, 1 HOUR AFTER VACCINATION (AT STUDY CLINIC)ADAY 1 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS B;SUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVWEHqA Vaccination 1DAY 2 A DAY 2 A SYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS B=SUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDV\EǀHqvxApVaccination 1DAY 7 ApDAY 7 ApSYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BBSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDV_DpHqޯ<AVaccination 1DAY 9 ADAY 9 ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BDSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDV_EmHqeXAVaccination 1DAY 10 ADAY 10ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BESUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDV`EKHq഼AVaccination 1DAY 11 ADAY 11ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BFSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVaES@HqAVaccination 1DAY 12 ADAY 12ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BGSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVbEHqd(AVaccination 1DAY 13 ADAY 13ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BHSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVcEHqĨAVaccination 1DAY 14 ADAY 14ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BISUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVdEHqAVaccination 1DAY 15 ADAY 15ASYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BJSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVeEHqfBVaccination 1DAY 16 BDAY 16BSYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BKSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVfEq@HqBVaccination 1DAY 17 BDAY 17BSYSTEMIC A MEDTAKP Prevent Pain or Fever from Occurring .Y .VS BLSUPPVS.QVAL where QNAM='MEDTAKP' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVYEHq}A@Vaccination 1DAY 4 A@DAY 4 A@SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS B?SUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDVZEHq|APVaccination 1DAY 5 APDAY 5 APSYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS B@SUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<BDV\DHqApVaccination 1DAY 6 A`DAY 6 A`SYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BASUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US208-1121US2081121US208USAB?YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYNYYNYYYYYYYNNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVVHqHDVyHr<HqHHr<DVyHr<B DV]EHqܤAVaccination 1DAY 8 ADAY 8 ASYSTEMIC A MEDTAKT Treat Pain or Fever already Occurred .Y .VS BCSUPPVS.QVAL where QNAM='MEDTAKT' mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVs..B"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A FACEEoFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqA0DVt..B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A FACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqAPDVu..B$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A FACEEoFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqApDVv..B%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A FACEEpFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVw..B&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A FACEEp0FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVx..B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A FACEEpPFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVy..B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .GRADE 2/MODERATE Grade 2A FAAEAFASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqA DVsDHqGB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEoFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqA@DVtD8Hq8B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEoFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqA`DVuDHqB$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVvDHqLB%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVwDHqLB&Vaccination 2DAY 6 A`DAY 6 A`SYSTEMIC A FATIGUE Fatigue .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEp@FASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVxD8Hq8B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEp`FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVyDHr/0B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A FATIGUE Fatigue .SOME INTERFERENCE WITH ACTIVITY Grade 2A FAAEA FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVx..B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .GRADE 2/MODERATE Grade 2A FACEEq`FASTRESC INVESTIGATOR Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVy..B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .GRADE 2/MODERATE Grade 2A FAAEA@FASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqADVsDHqGB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVtD8Hq8B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVuDHqB$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEq0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVvDHqLB%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFACEEq@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVxD8Hq8B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A HEADACHEHeadache .REPEATED USE OF OVER-THE-COUNTER PAIN RELIEVER > 24 HOURS OR SOME INTERFERENCE WITH ACTIVITY Grade 2A FACEEqpFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVyDHr/0B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A HEADACHEHeadache .NO INTERFERENCE WITH ACTIVITY Grade 1AFAAEAPFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVx..B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 2/MODERATE Grade 2A FACEEspFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVy..B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A NAUSEA Nausea/Vomiting .GRADE 2/MODERATE Grade 2A FAAEApFASTRESC INVESTIGATOR YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVsDHqGB"Vaccination 2DAY 2 A DAY 2 A SYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEs FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVtD8Hq8B#Vaccination 2DAY 3 A0DAY 3 A0SYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEs0FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVuDHqB$Vaccination 2DAY 4 A@DAY 4 A@SYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEs@FASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVvDHqLB%Vaccination 2DAY 5 APDAY 5 APSYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEsPFASTRESC STUDY SUBJECT YY mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVxD8Hq8B'Vaccination 2DAY 7 ApDAY 7 ApSYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFACEEsFASTRESC STUDY SUBJECT Y mRNA-1273-P201mRNA-1273-P201-US208-1129US2081129US208USAB:YEARS>=55 Years A >=55 Years A@FWHITE NOT HISPANIC OR LATINOYYYYYYYYYYYNYYYYYYYYNNYYNNot Detected NNNmRNA-1273 100 ugA0mRNA-1273 100 ugA0DVRHqDVrHqHqHqDVrHqBDVyDHr/0B(Vaccination 2DAY 8 ADAY 8 ASYSTEMIC A NAUSEA Nausea/Vomiting .NO INTERFERENCE WITH ACTIVITY OR 1-2 EPISODES/24 HOURS Grade 1AFAAEAFASTRESC STUDY SUBJECT Y